Browse GCSAM

Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Cytoplasm. Cell membrane. Note=It relocalizes from the cytoplasm to podosome-like structures upon cell treatment with IL6.
Domain PF15666 Germinal center-associated lymphoma
Function

Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation.

> Gene Ontology
 
Biological Process GO:0002429 immune response-activating cell surface receptor signaling pathway
GO:0002683 negative regulation of immune system process
GO:0002685 regulation of leukocyte migration
GO:0002686 negative regulation of leukocyte migration
GO:0002757 immune response-activating signal transduction
GO:0002764 immune response-regulating signaling pathway
GO:0002768 immune response-regulating cell surface receptor signaling pathway
GO:0030336 negative regulation of cell migration
GO:0040013 negative regulation of locomotion
GO:0050851 antigen receptor-mediated signaling pathway
GO:0050853 B cell receptor signaling pathway
GO:0050854 regulation of antigen receptor-mediated signaling pathway
GO:0050855 regulation of B cell receptor signaling pathway
GO:0050900 leukocyte migration
GO:0051271 negative regulation of cellular component movement
GO:0072676 lymphocyte migration
GO:2000146 negative regulation of cell motility
GO:2000401 regulation of lymphocyte migration
GO:2000402 negative regulation of lymphocyte migration
Molecular Function GO:0003779 actin binding
GO:0017022 myosin binding
GO:0045159 myosin II binding
Cellular Component -
> KEGG and Reactome Pathway
 
KEGG -
Reactome -
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between GCSAM and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of GCSAM in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of GCSAM in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)14120.1970.555
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)650.5780.309
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.0840.861
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 916-0.4550.334
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59-0.7260.651
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 47-0.1210.947
729033130MelanomaallAnti-PD-1 (nivolumab) 26231.140.0395
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15111.5310.07
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.850.33
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 481.1690.119
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 280.7830.445
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.1240.55
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of GCSAM in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 277301.4-1.41
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 275901.7-1.71
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21174.804.81
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13117.707.71
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38270001
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22130001
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 111307.7-7.71
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 51208.3-8.31
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of GCSAM. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of GCSAM. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by GCSAM.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of GCSAM. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of GCSAM expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between GCSAM and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolGCSAM
Namegerminal center-associated, signaling and motility
Aliases MGC40441; HGAL; human germinal center-associated lymphoma; GCET2; germinal center expressed transcript 2; GC ......
Chromosomal Location3q13.13
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting GCSAM collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.